348 related articles for article (PubMed ID: 27916281)
21. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.
Gerashchenko TS; Zavyalova MV; Denisov EV; Krakhmal NV; Pautova DN; Litviakov NV; Vtorushin SV; Cherdyntseva NV; Perelmuter VM
Acta Naturae; 2017; 9(1):56-67. PubMed ID: 28461975
[TBL] [Abstract][Full Text] [Related]
22. Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development.
Hashimoto O; Yoshida M; Koma Y; Yanai T; Hasegawa D; Kosaka Y; Nishimura N; Yokozaki H
J Pathol; 2016 Oct; 240(2):211-23. PubMed ID: 27425378
[TBL] [Abstract][Full Text] [Related]
23. Breast Carcinoma-associated Fibroblasts Share Similar Biomarker Profiles in Matched Lymph Node Metastasis.
Mundim FG; Pasini FS; Nonogaki S; Rocha RM; Soares FA; Brentani MM; Logullo AF
Appl Immunohistochem Mol Morphol; 2016; 24(10):712-720. PubMed ID: 26808127
[TBL] [Abstract][Full Text] [Related]
24. Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery.
Garvin S; Vikhe Patil E; Arnesson LG; Oda H; Hedayati E; Lindström A; Shabo I
Virchows Arch; 2019 Aug; 475(2):151-162. PubMed ID: 30915533
[TBL] [Abstract][Full Text] [Related]
25. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
26. Invasive and drug resistant expression profile of different morphological structures of breast tumors.
Denisov EV; Gerashchenko TS; Zavyalova MV; Litviakov NV; Tsyganov MM; Kaigorodova EV; Slonimskaya EM; Kzhyshkowska J; Cherdyntseva NV; Perelmuter VM
Neoplasma; 2015; 62(3):405-11. PubMed ID: 25672673
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic drift as a cause for intratumoral morphological heterogeneity of invasive ductal breast carcinoma not otherwise specified.
Zavyalova MV; Denisov EV; Tashireva LA; Gerashchenko TS; Litviakov NV; Skryabin NA; Vtorushin SV; Telegina NS; Slonimskaya EM; Cherdyntseva NV; Perelmuter VM
Biores Open Access; 2013 Apr; 2(2):148-54. PubMed ID: 23593567
[TBL] [Abstract][Full Text] [Related]
28. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
29. Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer.
Kim H; Lee KH; Park IA; Chung YR; Im SA; Noh DY; Han W; Moon HG; Jung YY; Ryu HS
Virchows Arch; 2015 Nov; 467(5):563-70. PubMed ID: 26280894
[TBL] [Abstract][Full Text] [Related]
30. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between Cancer Cells and Fibroblasts for the Production of Monocyte Chemoattractant Protein-1 in the Murine 4T1 Breast Cancer.
Imamura M; Li T; Li C; Fujisawa M; Mukaida N; Matsukawa A; Yoshimura T
Curr Issues Mol Biol; 2021 Oct; 43(3):1726-1740. PubMed ID: 34698088
[TBL] [Abstract][Full Text] [Related]
32. Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry.
Røgenes H; Finne K; Winge I; Akslen LA; Östman A; Milosevic V
Front Immunol; 2024; 15():1325191. PubMed ID: 38711512
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of CD68+ AND CD163+ macrophages in the primary focus and metastatic lesions of regional lymph nodes in non-luminal her2-positive invasive breast carcinoma.
Aikian AZ; Shynkevych VI; Kaidashev IP
Wiad Lek; 2019 Oct; 72(10):1861-1865. PubMed ID: 31932263
[TBL] [Abstract][Full Text] [Related]
35. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
37. Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44
Denisov EV; Skryabin NA; Gerashchenko TS; Tashireva LA; Wilhelm J; Buldakov MA; Sleptcov AA; Lebedev IN; Vtorushin SV; Zavyalova MV; Cherdyntseva NV; Perelmuter VM
Oncotarget; 2017 Sep; 8(37):61163-61180. PubMed ID: 28977854
[TBL] [Abstract][Full Text] [Related]
38. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment.
Galazka K; Opławski M; Windorbska W; Skret-Magierlo J; Koper K; Basta P; Mach P; Dutch-Wicherek M; Mazur A; Wicherek L
Am J Reprod Immunol; 2012 Jul; 68(1):85-93. PubMed ID: 22530960
[TBL] [Abstract][Full Text] [Related]
39. CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.
Raschioni C; Bottai G; Sagona A; Errico V; Testori A; Gatzemeier W; Corsi F; Tinterri C; Roncalli M; Santarpia L; Di Tommaso L
Dis Markers; 2018; 2018():5018671. PubMed ID: 29849822
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
